Cybin, Inc. HELP 深 滬
已收盤 08-07 16:00:00 美东时间
11.61
+0.510
+4.59%
華盛通- 最 高11.62
- 今 開11.21
- 成交量 173.99万股
- 最 低 11.052
- 昨 收 11.10
- 總市值 7.20亿
- 52周最高 11.62
- 市盈率 靜 --
- 換手率 2.81%
- 52周最低 3.76
- 委 比 22.45%
- 總股本 6198.41万
- 歷史最高 122.36
- 量 比 0.73
- 振 幅 5.12%
- 歷史最低 3.76
- 每 手 1
- 風險率 1.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Thursday. Shares of Abbott Laboratories (NYSE:ABT) rose sharply after the company reported better-than-expected second-quarter financial results and raised its FY26 adjusted EPS guidance. Abbott Laboratories posted quarte...
07-16 22:11
美股夜盘 | AtaiBeckley Inc.涨71.08%，Agape ATP涨53.97%
虎牙涨-12.50%；AST SPACEMOBILE涨-11.66%；巨龙在线涨-9.67%
07-16 08:05
美股夜盘 | 大自然药业涨187.16%，Decoy Therapeutics Inc.涨20.51%
LiveWire涨-10.87%；Pyxis Tankers, Inc.涨-9.05%；Cybin, Inc.涨-8.95%
06-29 08:05
美股牛股 | 航天零件制造商DPC上市首日大涨超42%！TECH涨超20%，获默克113亿美元溢价收购
航天零件制造商DPC上市首日大涨超42%！总市值超66亿美元；TECH涨超20%，获默克113亿美元溢价收购；黑莓涨20%，Q1营收超预期并上调财年业绩展望>>
06-26 15:20
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
美股大行评级 | 大摩上调哔哩哔哩目标价从25美元升至31美元；大砍近50%！汇丰下调耐克目标价从90美元降至48美元
今日重点评级关注：HC Wainwright & Co.：维持Solaris Resources"买入"评级，目标价从16美元升至18美元；Leerink Partners：维持Spyre Therapeutics"跑赢大市"评级，目标价从49美元升至106美元
04-14 10:44
TD Cowen Initiates Coverage On Helus Pharma with Buy Rating, Announces Price Target of $8
TD Cowen analyst Ritu Baral initiates coverage on Helus Pharma (NASDAQ:HELP) with a Buy rating and announces Price Target of $8.
04-13 22:27
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
Issued on behalf of Cybin D/B/A Helus Pharma USANewsGroup.com News Commentary VANCOUVER, BC, March 9, 2026 /PRNewswire/ -- The central nervous system therapeutics sector is approaching a com...
03-09 22:50
Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints
Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pressure on the stock.
03-05 23:38
